SCHEMBL10399799

SCHEMBL10399799

COc1ccc(N2C(=O)C(=CN(C)C)c3ccccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
HSD17B10 Q99714 1/20 0.52
KDM4E B2RXH2 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
GAA P10253 1/20 0.50
MAPT P10636 9/20 0.49
APP P05067 5/20 0.49
SNCA P37840 5/20 0.49
NR1H3 Q13133 1/20 0.49
PGR P06401 1/20 0.46
RPS6KA2 Q15349 1/20 0.45
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10399797 1.00 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4ECASP3SENP8
SCHEMBL10399644 0.87 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL10399645 0.87 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL10399734 0.86 MAPT (0.63) ALDH1A1HSD17B10KDM4ECASP3SENP8
SCHEMBL10399731 0.86 MAPT (0.63) ALDH1A1HSD17B10KDM4ECASP3SENP8
SCHEMBL10398711 0.85 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL10398712 0.85 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL10399649 0.84 MAPT (0.68) ALDH1A1HSD17B10GAAMAPTAPP
SCHEMBL10806982 0.84 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL10399648 0.84 MAPT (0.68) ALDH1A1HSD17B10GAAMAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4977178-A Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents PFIZER INC. (US) 1990-12-11 US disclosed
US-4879391-A 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents PFIZER INC. (US) 1989-11-07 US disclosed
US-4861880-A 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents PFIZER INC. (US) 1989-08-29 US disclosed
EP-0104860-B1 1-PHENYL-2(1H,3H)-INDOLONE PSYCHO-THERAPEUTIC AGENTS PFIZER INC. (US) 1987-03-18 EP disclosed
US-4476307-A Heteroylidene indolone compounds PFIZER INC. (US) 1984-10-09 US disclosed
EP-0104860-A1 1-Phenyl-2(1H,3H)-indolone psycho-therapeutic agents PFIZER INC. (US) 1984-04-04 EP disclosed